See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
---|---|---|---|
$10.1B | n/a | n/a | |
$8.4B | 6.9x | 19.9x | |
$1.7B | 8.4x | -27.2x | |
$1.5B | 5.4x | -10.2x | |
$928M | n/a | n/a | |
$186M | 10.1x | 13.2x | |
$183M | 2457.5x | -5.3x | |
$168M | n/a | n/a | |
$46.5M | 2.8x | 13.8x | |
$39.0M | 15.5x | -9.6x | |
$21.5M | n/a | n/a | |
$20.0M | 15.3x | -9.1x | |
$6.0M | n/a | n/a | |
-$9.1M | n/a | 0.1x | |
-$24.2M | -0.9x | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics